PMA device
Low-Profile Visualized Intraluminal Support (LVIS), LVIS Jr
MicroVention, Inc. · Intracranial Coil-Assist Stent (QCA, Class III) · First FDA decision May 30, 2018, newest Aug 21, 2024Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
9
Naming "Low-Profile Visualized Intraluminal"
MAUDE reports
2
Brand "Low-Profile Visualized Intraluminal", since 2015
PubMed studies
160
Mentioning "Low-Profile Visualized Intraluminal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Low-Profile Visualized Intraluminal Support (LVIS), LVIS Jr
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
P170013-S012 · Decided Aug 21, 2024 · 160 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial coil-assist stent (QCA) · Neurology & Neurosurgery
P170013-S010 · Decided Dec 9, 2022 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial coil-assist stent (QCA) · Neurology & Neurosurgery
P170013-S009 · Decided Jun 28, 2022 · 18 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial coil-assist stent (QCA) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Older decisions: P170013-S003, P170013
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Intracranial Stenting and AngioplastyNational analysisReview closedCAG-00085R5Updated Sep 18, 2026
- Intracranial Stenting and AngioplastyNational analysisReview closedCAG-00085R2Updated Sep 18, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Low-Profile Visualized Intraluminal", any status and sponsor, newest update first.
Microvention-Terumo, Inc.Public (4543.T)
NCT01541254 · 30 participants · Start Mar 2012 · Primary completion Jun 2013
Device: Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.) · For: Intracranial Aneurysms
Sites: Albany, New York; Stony Brook, New York; Philadelphia, Pennsylvania · 6 sites in all
- Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support)Pivotal-lookingCompleted
Microvention-Terumo, Inc.Public (4543.T)
NCT01793792 · 153 participants · Start Jul 2013 · Primary completion Nov 2015
Device: LVIS™ and LVIS™ Jr · For: Intracranial Aneurysms
Sites: Phoenix, Arizona; Carmichael, California; Englewood, Colorado · 21 sites in all
Microvention-Terumo, Inc.Public (4543.T)
NCT02921711 · 90 participants · Start Jun 2012 · Primary completion Apr 2016
Device: LVIS® · For: Intracranial Aneurysms
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Low-Profile Visualized Intraluminal", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 0 injury, 2 death
Whole product code QCA
880 reports: 599 malfunction, 270 injury, 11 death
Newest reports for this brand
MICROVENTION, INC; WORLDWIDE HEADQUARTERS
5936835 · Received Sep 2, 2016 · Event dated Aug 16, 2016 · 1 other device named on this report
Device type: Intracranial Neurovascular Stent (NJE)
Device problem as coded: Migration or Expulsion of Device; Device Dislodged or Dislocated; Activation Failure
Patient problem as coded: Death; Hemorrhage, Subarachnoid; Coma
MICROVENTION INC., A TERUMO GROUP COMPANY
5726025 · Received Jun 15, 2016 · Event dated Jun 6, 2016
Device type: Intracranial Neurovascular Stent (NJE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Aneurysm; Death
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2200-2026 · Started Apr 6, 2026 · Posted by FDA May 14, 2026
Reason given: Stent-assisted coiling device may due to commingling during manufacturing have dimensional nonconformance and/or incorrect device configuration. If device is oversized may lead to increased vessel wall stress, neointimal hyperplasia, vessel injury/rupture; if undersized may lead to incomplete expansion/malposition,...
Cause as FDA categorized it: Mixed-up of materials/components · Device type: Intracranial Coil-Assist Stent (QCA)
Z-1121-2025 · Started Dec 11, 2024 · Posted by FDA Feb 7, 2025
Reason given: Potential for Polytetrafluoethylene (PTFE) material encasing the stent loop may prevent the stent from being pushed out of the introducer.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Intracranial Coil-Assist Stent (QCA)
Published research
The most relevant PubMed records for "Low-Profile Visualized Intraluminal"[tiab]. The summary above synthesizes these.
- Low-profile visualized intraluminal support stent for the endovascular treatment of traumatic intracranial internal carotid artery pseudoaneurysms.
Tan S, Zhou X, Lu Y, et al. · Neurosurg Rev · 2022
- Low-Profile Visualized Intraluminal Support Device for Y-Stent-Assisted Coiling of Wide-Neck Intracranial Aneurysms: A Single-Center Experience.
Saghebdoust S, Qoorchi Moheb Seraj F, Najafi S, et al. · World Neurosurg · 2024
- Low-profile visualized intraluminal support-within-Enterprise overlapping-stent technique versus flow diversion in the treatment of intracranial vertebrobasilar trunk dissecting aneurysms.
Wu Q, Wang C, Xu S, et al. · Quant Imaging Med Surg · 2023
- [Simulation for Endovascular Treatment].
Kato N, Fujimura S, Sano T, et al. · No Shinkei Geka · 2024English Abstract
- Utility of low-profile visualized intraluminal support (LVISࡊ) stent for treatment of acutely ruptured bifurcation aneurysms: A single-center study.
Liu C, Guo K, Wu X, et al. · Front Neurol · 2023
- Enterprise stents versus low-profile visualized intraluminal support stents for stent-assisted coiling of unruptured paraclinoid aneurysms.
Wu ZP, Yin JL, Liu SK, et al. · Technol Health Care · 2023
- Safety and efficacy of the Low-Profile Visualized Intraluminal Support stent in treating intracranial atherosclerotic stenosis.
Wang JW, Li XY, Li CH, et al. · Neurologia (Engl Ed) · 2023
- Low profile visualized intraluminal support stent-assisted Hydrocoil embolization for acutely ruptured wide-necked intracranial aneurysms: A propensity score-matched cohort study.
Jiang W, Zuo Q, Xue G, et al. · Clin Neurol Neurosurg · 2022
- Results of Double Low-Profile Visualized Intraluminal Support Blue Stenting for the Treatment of Fusiform Cerebral Aneurysms.
Ban SP, Kwon OK, Kim YD, et al. · World Neurosurg · 2023
- Low-Profile Visualized Intraluminal Support Jr Braided Stent Versus Atlas Self-Expandable Stent for Treatment of Intracranial Aneurysms: A Single Center Experience.
Monteiro A, Cortez GM, Aghaebrahim A, et al. · Neurosurgery · 2021
- Low-Profile Visualized Intraluminal Support Stent-Only Technique for Intracranial Aneurysms-A Report of 12 Cases with Midterm Follow-Up.
Liu Q, Qi C, Zhang Y, et al. · World Neurosurg · 2019Clinical Trial
- Low-Profile Visualized Intraluminal Support Junior Flow-Diversion Properties Used for Stabilization of a Superior Cerebellar Artery Pseudoaneurysm.
Winter KA, Derrico NP, Ziemke MK, et al. · World Neurosurg · 2023Case Reports
Other devices of this type
Also filed under product code QCA.
- Neuroform Atlas® Stent SystemStryker Neurovascular · PMA 2026
- LVIS and LVIS Jr.MicroVention, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.